Aesica Recruits Operations Director in Formulated Products Business Unit
News Feb 05, 2013
Aesica has appointed Jarrett Palmer as Operations Director of its formulated products business unit business.
Palmer has accumulated over 15 years’ experience in senior leadership positions and has managed facilities for global CMOs including Catalent Pharma Solutions and Piramal Healthcare.
Based at Aesica headquarters in Newcastle (UK), Palmer will report to Chris Gowland , Managing Director of Formulated Products.
Operations at the Queenborough facility (UK) and recently acquired sites in Europe - including Monheim and Zwickau (Germany) and Pianezza (Italy) - will be managed by Palmer who will coordinate operational activities around the company’s commercial scale manufacturing, packaging and distribution activities.
Pivotal to this new role is the continued sustainable growth of Aesica, which includes continuous improvement to drive manufacturing efficiency and managing growing demand for potent manufacturing from the company’s UK base.
“We are delighted to have Jarrett Palmer join Aesica as Operations Director. He brings significant experience with a long and established track record of managing sites for global CMOs. Jarrett’s role is central to the maintenance of high standards at our FDA approved commercial scale manufacturing sites. He will be critical to the acquisition process and will support senior management in identifying global acquisition targets and transitioning new sites in line with our exacting efficiency and quality standards”, commented Chris Gowland Managing Director of Formulated Products at Aesica.
“Aesica is one of the most exciting names in contract manufacturing at the moment”, added Palmer on his decision to join the company. “It has big plans for growth which will significantly increase its global footprint and its manufacturing and packaging capacity at commercial scale, which is what the market has a great demand for. The prospect of being at the heart of this dynamic business is what attracted me to Aesica. My goal is to ensure that at every step, we optimize our internal infrastructure so that our customers enjoy responsiveness and efficiency in all interaction with us.”
Uptake of Controlled Release Drug Delivery Technology Set to Increase?News
The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.READ MORE
Novel Artificial Photosynthesis Device for Greener Ethylene ProductionNews
A team of scientists from the National University of Singapore (NUS) has developed a prototype device that mimics natural photosynthesis to produce ethylene gas using only sunlight, water and carbon dioxide.READ MORE